#GENEO

[ithilien-bjd]

Can't believe my dingledolt of a self forgot to post these on here! Took some photos of Eko to celebrate my camera getting back from repair

[struungout]

Been a while since I’ve snapped a picture of Qianna. Naturally it’s gotta be her with her man on a leash lmao.

[dreemurr-skelememer]

all i thinkg aout is geno

[starscorners]

Grissom was known for his athleticism and versatility on the football field, playing multiple positions on defense, including defensive end and outside linebacker. He was also active in charitable endeavors, volunteering with the Boys & Girls Clubs of America and participating in community service events with his former team.

[very-best-vivosaur]

Very SPECIAL Vivosaur: Round 1

Propaganda under the cut!

Lugmos Propaganda:

This was my first Super Evolved. Such a good shade of red and blue!

Geneos Propaganda:

Always loved that this guy had poison skills

[itsadragonaesthetic]

Link to preliminaries masterpost

[cpopfans520]

微博：鄧紫棋工作室

#鄧紫棋 | #鄧紫棋Geneox全球品牌代言人

Geneo X全球品牌代言人@GEM鄧紫棋 來了！

和天生麗質的解解一起呵護肌膚，解鎖耀Young活力人生～

📷 鄧紫棋工作室

[ithilien-bjd]

Did some lighting experimenting with Eko, since I need to learn more than ambient light photography.

[struungout]

Spent about an hour yesterday taking my dremel to Vergil’s Raccoon Doll body to make the neck thinner so his head fits on it better.

Wish I thought take proper before pictures, but here’s an idea of what it was like before haha.

[bhushans]

A Market on the Move: Exploring Investment Opportunities in Global Microdermabrasion Devices Market

The global microdermabrasion devices market is projected to see significant growth over the next decade, with market size estimated to increase from USD 514.8 million in 2023 to USD 864.2 million by 2033. This growth represents a compound annual growth rate (CAGR) of 5.3% from 2023 to 2033.

In 2022, the market size for microdermabrasion devices was recorded at USD 490.8 million. The market’s upward trajectory is attributed to technological advancements in microdermabrasion devices, which are expected to enhance their popularity among consumers, thus positively impacting market growth.

Microdermabrasion, a mechanical exfoliation technique used to remove the outermost layer of dead skin cells, is increasingly being adopted by end-users for its effectiveness in skin treatment. This technique’s growing acceptance is anticipated to drive the demand for microdermabrasion devices, contributing to the market’s expansion.

Your Insightful Report Sample With Your Work Email : https://www.futuremarketinsights.com/reports/sample/rep-gb-5054

This exfoliation technique improves the skin’s tone and texture while exposing fresh, soft, and smooth skin cells. Skin can better absorb anti-aging and acne products after medical microdermabrasion. Through stimulation of the underlying epidermis, which promotes the generation of new collagen, the technique also thickens the dermis and boosts resistance to the aging process.

The goal of any microdermabrasion procedure is to get rid of dead skin. Many surface problems, such as dullness, mild to moderate acne, hyperpigmentation, and fine wrinkles, can be resolved by microdermabrasion. Crystal microdermabrasion involves spraying fine crystals over the face with a wand. Dead skin is removed as the skin abrades across the skin and is collected by the associated vacuum. The majority of crystals used in crystal microdermabrasion are organic sodium bicarbonate or nontoxic aluminum oxide.

Competitive Analysis:

Some of the prominent players working in the global market are-

Altair Instruments

Lumenis Ltd

Sylvan Company

ImageDerm Inc

PMD Beauty

Kosmet, Inc

Johnson & Johnson

Dermamed Solutions

MacroDerma.com

Dermaglow

Recent Developments in the Microdermabrasion Devices Market

In September 2018, the company Candela Corporation obtained the Ellipse A/S which is one of the leading companies for intense pulsed light and is a laser-based platform for skin care treatments. Therefore through the acquisitions, Candela wanted its products to be strengthened in the marketplace.

In April 2016, The USA-based DermaMed Solution launched its new technical products in Philadelphia for skin care treatment. The new product – geneO+ 3 in 1 Super Facial helps to light fine lines and wrinkles. It is one of the latest technology with a motto to take care of the skin naturally.

In November 2022, Johnson & Johnson announced its intent for separating the Company’s Consumer Health business, by creating a new publicly traded company. The planned separation created two global leaders that are better positioned in delivering improved health outcomes for patients and consumers through innovation, pursue more targeted business strategies and accelerate growth.

In December 2022, Johnson & Johnson took another step forward in the establishment of two independent, market-leading companies with the announcement of Kenvue as the name for the planned New Consumer Health Company. The new corporate brand comes to life through a compelling purpose and a timeless visual brand.

Key Segmentation

By Type:

Diamond Microdermabrasion Devices

Crystal Microdermabrasion Devices

By Application:

Acne

Minor Acne Scarring

Enlarged and Clogged Pores

Spots and Blemishes

Fine Lines and Wrinkles

Uneven Skin Tone

Coarse Skin Texture

Saggy Skin

By End User:

Hospitals

Dermatology Clinics

Spas and Beauty Parlors

By Region:

North America

Latin America

The Middle East and Africa

Europe

Asia Pacific

[cyberturtledreamland]

งานซ่อมรถโฟล์คลิฟต์ / forklift toyota GENEO-R / รถยกฟอร์คลิฟต์ไฟฟ้า Electric Lift Truck TOYOTA Geneo Model 7FBR10 SN 50778 YrMo201312 [ M/D : 7FBR10 S/N : 7FBR10-50778 ]

[decentralvaccine]

A New Vaccine Shrinks Liver Tumors

Nearly a third of patients with advanced liver cancer who received a personalized vaccine developed by Geneos Therapeutics along with an immunotherapy drug in a small, early trial saw their tumors shrink, U.S. researchers reported on Sunday.

The result was roughly twice the response typically seen with the immunotherapy alone, the researchers said.

Findings from the preliminary study, presented at the American Association for Cancer Research in San Diego and published in Nature Medicine, suggests that vaccines based on mutations only present in a patient’s tumor may boost the immune system’s ability to recognize and attack hard-to-treat cancers.

https://www.theglobeandmail.com/business/article-geneos-cancer-vaccine-shrinks-liver-tumors-in-small-trial/

[ramtracking]

Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: a phase 1/2 trial [ Clinical trial ]

Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: a phase 1/2 trial [News Summary] Programmed cell death protein 1 (PD-1) inhibitors have modest efficacy as a monotherapy in hepatocellular carcinoma (HCC). Findings from the preliminary study suggests vaccines based on mutations only present in a patient’s tumor may boost the immune system’s… Geneos has…